These data indicate that metformin can thwart activated HSC-induced tumor progression of residual HCC cells after heat treatment through suppressing POSTN secretion and decreasing the expression of cancer stem cell markers. The gene discussed is POSTN; the disease is hepatocellular carcinoma.